Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Boehringer Ingelheim announces ERS COPD award winners

Boehringer Ingelheim announces ERS COPD award winners

17th September 2007

Boehringer Ingelheim has announced the winners of the European Respiratory Society (ERS) awards in the field of chronic obstructive pulmonary disease (COPD).

Sponsored by the firm, the accolade was awarded this year to Dr Morton Dahl of Herlev University Hospital in Copenhagen and Simonetta Baraldo of Padova, Italy.

The award seeks to recognise the work of younger European members of the society for their work in pulmonology and includes two sponsorships for COPD research products totalling 50,000 euros (33,400 pounds).

Dr Dahl received the first prize for his work in assessing the risk of contracting COPD in patients with increased systemic inflammation with a less severe deficiency of alpha-1 antitrypsin, while Simonette Baraldo won the second prize for research work exploring the link between functional abnormalities in COPD and asthma and excessive inflammatory response.

William MacNee, president of the ERS, expressed congratulations for the two winners for their work resulting in the awards.

“We would also like to take this opportunity to thank all applicants for the high standard of work submitted,” he said.

“Thanks are also due to Boehringer Ingelheim, a leader in the research and treatment of COPD, for making this award possible.”

In March 2007, Boehringer Ingelheim joined Novartis, Eli Lilly and AstraZeneca as founding sponsors of the Massachusetts Institute of Technology Centre for Biomedical Innovation.

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.